CR3 News Magazine 2020 VOL 3: MAY Medical - Radon vs Covid-19 | Page 41

41

Dr. Chrysan Cronin is an Assistant Professor and the Director of Public Health at Muhlenberg College. She and her students focus on efforts to improve the health of communities on and around campus, including awareness campaigns about radon risks and opioid overdoses.

Learn more about clinical studies related to COVID-19:

ClinicalTrials.gov: Federally-funded clinical studies related to COVID-19

WHO Trial Registry Network: COVID-19 studies from the ICTRP database

CDC: Information for Clinicians on Therapeutic Options for COVID-19 Patients

NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

... continued from pg 31 (Covid-19 Public Health Response)

they don’t behave similarly with radon. This behavior results from the level of perceived risk,which is a personal assessment of the likelihood of being harmed. Perceived risk can be influenced by a number of factors including the amount of media attention and the ways in which policy makers react to the risk. It can also be influenced by the imminence of the threat. Exposure to COVID19 may result in symptomatic and even serious illness in just 14 days, which can seem far more daunting than the long latency period associated with radon exposure. The 24-hour news coverage with a death count rolling across the screen, the daily press briefings at both the federal and state levels, and the new and ever-changing policies that are intended to keep us safer have all increased our levels of perceived risk and prompted us to take appropriate actions to stay safe. We are willing to wear masks at the grocery store, stay home from work, and shut down businesses to stay safe from COVID19, yet only a small percentage of people in the US test their homes for deadly radon gas. The challenge for those of us who work on radon is to achieve a similar level of public commitment and vigilance in mitigating exposure to radon. This can be best accomplished by getting our policy makers to take radon risk more seriously and implement policies and laws that require testing and mitigation.

###

COVID-19 CLINICAL TRIALS